ONE Bio Corp. (ONBI) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

ONE Bio Corp. (ONBI) Healthcare & Pipeline Overview

ONE Bio Corp. is an agritech company leveraging green process manufacturing to produce raw chemicals, herbal extracts, natural supplements, and organic products. Operating through Chemical and Herbal Extracts (CHE) and Organic Products (OP) units, it serves bio-health and raw chemical industries in China, with exports to Japan, Europe, and North America.

What Is the Investment Thesis for ONBI?

ONE Bio Corp. presents a unique profile as an agritech company leveraging green process manufacturing across two distinct business units: Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE unit capitalizes on the growing demand for natural health and wellness ingredients, producing compounds like Solanesol, Coenzyme Q10, Resveratrol, and 5-Hydroxytryptophan, alongside bio-ecological fertilizers. This unit's focus on the bio-health and raw chemical intermediates industries in China, distributed through specialized channels, provides a stable revenue stream. The OP unit addresses the expanding global market for organic food and beverages, particularly with its bamboo-based products and traditional Japanese dishes like Kamameshi, distributed directly to retail and hospitality sectors, and through third-party networks. The company's impressive Gross Margin of 38.5% and Profit Margin of 16.6% suggest efficient operations and strong product pricing power within its niche markets. Its export reach to Japan, Southeast Asia, Europe, and North America indicates potential for international market penetration. However, the company's listing on the OTC Other tier, coupled with an "Unknown" disclosure status and a high Beta of 6.22, introduces significant liquidity and transparency risks that warrant careful consideration by institutional investors. Future growth is contingent on continued product innovation, market expansion, and enhanced financial transparency.

Based on FMP financials and quantitative analysis

ONBI Key Highlights

Gross Margin of 38.5% indicates strong cost management and pricing power for its specialized chemical, herbal, and organic products.

• Profit Margin of 16.6% reflects efficient operational execution and profitability within its agritech and bio-ecological manufacturing segments.
• A workforce of 358 employees supports its dual business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP), across manufacturing and distribution.
• The company maintains an international export presence, distributing products to Japan, Southeast Asia, Europe, and North America.
• A Beta of 6.22 suggests significantly higher volatility compared to the broader market, which is a key consideration for risk assessment.

Who Are ONBI's Competitors?

ONBI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ONBI's Key Strengths?

Proprietary green process manufacturing approach.

• Diverse product portfolio across two distinct business units (CHE and OP).
• Established distribution channels in China and international export presence.
• Strong gross margin (38.5%) and profit margin (16.6%) indicating operational efficiency.

What Are ONBI's Weaknesses?

OTC Other tier listing, potentially limiting institutional investor access and liquidity.

• "Unknown" disclosure status, which can raise transparency concerns.
• High Beta (6.22) suggests significant stock price volatility.
• Limited public information regarding management background and track record.

What Could Drive ONBI Stock Higher?

ONBI catalyst: Potential expansion of its green process manufacturing capabilities to meet increasing demand for bio-ecological products in new markets.

• Introduction of new specialized chemical extracts or organic food product lines, leveraging its expertise in plant-based materials.
• Growing consumer and industrial demand for natural health ingredients and organic food products, particularly in its export markets.
• Any future initiatives to improve financial disclosure or transparency, potentially leading to increased investor confidence.

What Are the Key Risks for ONBI?

Significant liquidity challenges and wide bid-ask spreads inherent with trading on the OTC Other tier, potentially hindering investor entry and exit.

• The "Unknown" disclosure status creates substantial transparency risks, making it difficult for investors to accurately assess financial health and operational performance.
• High Beta of 6.22 indicates extreme price volatility, exposing investors to greater market fluctuations compared to broader indices.
• Regulatory changes in the People's Republic of China or international export markets could impact product approvals, manufacturing standards, or trade agreements.
• Intense competition from larger, more established players in the biotechnology, agritech, and organic food sectors, potentially limiting market share growth.

What Are the Growth Opportunities for ONBI?

• **Expansion in Natural Health Extracts Market:** The global market for natural health products and supplements is projected for sustained growth, driven by an aging population and increasing consumer focus on holistic well-being. ONE Bio Corp.'s Chemical and Herbal Extracts (CHE) unit, with products like Solanesol, Coenzyme Q10, Resveratrol, and 5-Hydroxytryptophan, is well-positioned to capitalize on this trend. By expanding its portfolio of plant-derived compounds and increasing distribution channels beyond China to its existing export markets in Japan, Europe, and North America, the company can tap into a larger consumer base seeking scientifically backed natural ingredients. This growth could be realized over the next 3-5 years through strategic partnerships and enhanced marketing efforts.
• **Growing Demand for Organic Food and Beverages:** The organic food and beverage market, particularly in Asia and North America, continues to expand rapidly as consumers prioritize healthier, sustainably produced options. ONE Bio Corp.'s Organic Products (OP) unit, specializing in bamboo-based foods, health drinks, and traditional dishes like Kamameshi, directly addresses this demand. Leveraging its established distribution networks in China (supermarkets, hotels, restaurants) and expanding its export footprint, the company can capture a larger share of this market. Introducing new organic product lines and innovative bamboo applications could significantly boost revenue, with substantial market penetration achievable within a 2-4 year timeframe.
• **Leveraging Green Process Manufacturing for Market Differentiation:** ONE Bio Corp.'s commitment to "green process manufacturing" offers a significant competitive advantage in an increasingly environmentally conscious global market. This sustainable approach to producing raw chemicals, herbal extracts, and organic products resonates with both consumers and business partners who prioritize eco-friendly sourcing and production. By actively promoting its green credentials and potentially seeking relevant certifications, the company can enhance its brand image, attract environmentally conscious customers, and command premium pricing. This differentiation strategy can strengthen market position and foster long-term growth over the next 5-7 years.
• **Penetration of the Bio-Ecological Fertilizer Market:** The CHE business unit also produces powdered and particulate fertilizers, aligning with the global shift towards sustainable agriculture and bio-ecological farming practices. As agricultural industries worldwide seek to reduce reliance on synthetic chemicals and improve soil health, the demand for organic and bio-ecological fertilizers is expected to rise. ONE Bio Corp. can expand its market share in this segment by developing new formulations, increasing production capacity, and forging partnerships with agricultural cooperatives and large-scale farming operations, initially in China and then in other export regions. This represents a substantial growth opportunity over the medium to long term (3-7 years).
• **Geographic Expansion in Export Markets:** While ONE Bio Corp. currently exports to Japan, Southeast Asia, Europe, and North America, there is significant potential for deeper market penetration and expansion into new countries within these regions. By strengthening its distribution networks, adapting products to local tastes and regulatory requirements, and increasing brand awareness in these diverse markets, the company can unlock considerable revenue growth. Focusing on specific high-growth segments within these regions, such as the natural health supplements market in Europe or the organic food market in North America, could yield substantial returns over the next 3-6 years.

What Threats Does ONBI Face?

• Intense competition from established players in the biotechnology, agritech, and organic food sectors.
• Regulatory changes in China or international export markets affecting product approvals or trade.
• Supply chain disruptions for key plant materials like tobacco leaves and bamboo.
• Potential for limited capital access and investor confidence due to OTC listing.

What Are ONBI's Competitive Advantages?

• **Green Process Manufacturing:** A proprietary focus on environmentally sustainable production methods for chemicals, extracts, and organic products, appealing to eco-conscious markets.
• **Diverse Product Portfolio:** A broad range of offerings spanning specialized chemical extracts, herbal supplements, organic food products, and fertilizers, diversifying revenue streams.
• **Established Distribution Networks:** Robust channels in China, including direct sales to major retailers and hospitality, alongside third-party distributors, and an existing export infrastructure.
• **Specialized Plant Material Expertise:** Unique capabilities in extracting valuable compounds from specific plant materials like tobacco leaves and bamboo, creating niche product lines.

What Does ONBI Do?

ONE Bio Corp., incorporated in 2000 and headquartered in Aventura, Florida, has evolved into an agritech company focused on sustainable manufacturing. Initially known as ONE Holdings, Corp., the company rebranded to ONE Bio Corp. in November 2009, signaling its commitment to bio-ecological and organic product development. The company operates through two distinct yet complementary business units: Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit is dedicated to the development, manufacture, and commercialization of bio-ecological and over-the-counter products. This unit specializes in utilizing green process manufacturing techniques for the extraction of compounds from tobacco leaves and various other plant materials. Its product portfolio includes chemical extracts such as Solanesol and Coenzyme Q10, which are vital components in a range of health and wellness products. Additionally, the CHE unit produces herbal extracts like Resveratrol, 5-Hydroxytryptophan, and Ganoderma Tea, known for their health benefits. This unit also manufactures powdered and particulate fertilizers. Distribution for the CHE unit primarily targets the bio-health industry and raw chemical intermediates industry within the People's Republic of China, facilitated through a network of independent third-party distributors, universities, and hospital research centers. The OP business unit focuses on the manufacturing of various consumer and commercial health and energy drinks, organic food products, and fertilizers, with a primary emphasis on bamboo-based ingredients. Its product offerings are diverse, including staples like boiled bamboo shoot cans (both regular and vacuum-packed), boiled mixed vegetables, boiled seasoned vegetables, and Kamameshi, a traditional Japanese rice dish. This segment's distribution strategy involves direct sales to supermarket chains, hotels, hospitals, and restaurants, alongside leveraging a network of independent third-party distributors, predominantly within the People's Republic of China. Beyond its domestic market, ONE Bio Corp. has established an international presence, exporting its products to key markets including Japan, Southeast Asia, Europe, and North America, underscoring its global reach in the agritech and organic product sectors. The company currently employs 358 individuals, contributing to its operational capabilities across its diverse product lines.

What Products and Services Does ONBI Offer?

• Utilizes green process manufacturing to produce raw chemicals and herbal extracts.
• Develops and commercializes bio-ecological and over-the-counter products from plant materials.
• Produces chemical extracts like Solanesol and Coenzyme Q10 for health and wellness.
• Manufactures herbal extracts such as Resveratrol, 5-Hydroxytryptophan, and Ganoderma Tea.
• Produces powdered and particulate fertilizers for agricultural use.
• Manufactures consumer and commercial health and energy drinks, primarily bamboo-based.
• Creates organic food products, including boiled bamboo shoot cans and Kamameshi.
• Exports products to Japan, Southeast Asia, Europe, and North America.

How Does ONBI Make Money?

• Generates revenue through the sale of specialized chemical and herbal extracts to the bio-health and raw chemical intermediates industries in China.
• Earns income from the manufacturing and direct sale of organic food products, health drinks, and bamboo-based items to supermarkets, hotels, and restaurants in China.
• Utilizes a network of independent third-party distributors for both its Chemical and Herbal Extracts (CHE) and Organic Products (OP) units.
• Engages in international trade by exporting its diverse product portfolio to markets in Japan, Southeast Asia, Europe, and North America.

What Industry Does ONBI Operate In?

ONE Bio Corp. operates at the intersection of the agritech, biotechnology, and organic products industries, carving out a specialized niche through its green process manufacturing. While the AI insight broadly categorizes it within "biotechnology," its core activities are more precisely aligned with the production of bio-ecological raw chemicals, herbal extracts, and organic food items derived from plant materials like tobacco leaves and bamboo. This positioning allows the company to tap into several burgeoning market trends. The global demand for natural health supplements and ingredients is experiencing robust growth, driven by increasing consumer awareness of wellness and preventative health. Simultaneously, the organic food and beverage market continues its expansion, fueled by preferences for sustainable and chemical-free products. ONE Bio Corp.'s focus on green processes provides a competitive advantage in an era where environmental sustainability is a key purchasing criterion. The competitive landscape includes specialized chemical extractors, herbal supplement manufacturers, and organic food producers, both local and international, particularly within its primary market, the People's Republic of China, and its export destinations.

Who Are ONBI's Key Customers?

• Bio-health industry companies and research centers in the People's Republic of China.
• Raw chemical intermediates industry clients in the People's Republic of China.
• Supermarket chains, hotels, and restaurants within the People's Republic of China.
• Independent third-party distributors serving various industries and consumer segments.
• International markets including Japan, Southeast Asia, Europe, and North America, through export channels.

Company Profile

ONE Bio Corp. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Aventura, US. The company is led by CEO Jian Ming Chan. ONBI has traded publicly since 2009.

ONE Bio Corp.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.95 places it in the grey zone, a middle ground that warrants monitoring.

Return on equity for ONE Bio Corp. stands at 24.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 12.4%, showing how much profit it generates from its asset base. ONBI trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~23x. A current ratio of 1.48 indicates the company holds enough short-term assets to cover its near-term obligations.

ONBI Valuation & Market Position

Relative to its peer group, ONBI's quantitative score of 57/100 is below the peer average of 76/100.

ONBI Financials

ONBI Latest News

No recent news available for ONBI.

ONBI Analyst Consensus

ONBI MoonshotScore

Common Questions About ONBI (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources